OR51E2 and prostate carcinoma: The mRNA level of PSGR increases significantly in the epithelial cells of prostate intraepithelial neoplasia (PIN) and PCa compared to non-cancerous controls and benign prostatic hyperplasia (BPH), suggesting that PSGR may play important roles in prostate cancer development and progression [2–4].